Showing 20 of 61 recruiting trials for “upington-disease”
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
iMagemHTT-009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease
Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis
👨⚕️ Sebastian H Unizony, M.D., Massachusetts General Hospital: Rheumatology, Allergy and Immunology, Center for Immunology and Inflammatory Diseases📍 7 sites📅 Started Dec 2025View details ↗
RecruitingNCT07253038 ↗
Evaluation of Three Tests to Assess Social Cognition in Huntington Disease
👨⚕️ Asa Petersen, MD PhD, Department of Psychiatry, Skåne University Hospital📍 1 site📅 Started Dec 2025View details ↗
Modification of Threat Interpretation Bias to Reduce Anxiety in Neurodegenerative Movement Disorders (Aim 3)
RecruitingNCT07084480 ↗
Giant Cell Arteritis - Ways to Precision Medicine
oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
Home-based TDCS (Transcranial Direct Current Stimulation) for Cognitive and Behavioral Symptoms in Huntington's Disease
👨⚕️ Thiago Macedo e Cordeiro, MD, MSc, The University of Texas Health Science Center at San Antonio📍 1 site📅 Started Sep 2025View details ↗
RecruitingNCT06774443 ↗
Hinting Task for Huntington's Disease
RecruitingNCT06894602 ↗
Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis
RecruitingNCT05749094 ↗
Optic Nerve Sheath Ultrasound in Giant Cell Arteritis
👨⚕️ Jean-Paul Makhzoum, MD, Vasculitis Clinic, Hopital du Sacre-Coeur de Montreal, University of Montreal📍 6 sites📅 Started Aug 2025View details ↗
Digital Measures for Clinical Trial Endpoints in Huntington's Disease
RecruitingNCT06546488 ↗
Cognitive Assessment Tools for Huntington's Disease.
RecruitingNCT06448546 ↗
Gut Microbiomes in HD
Study of SKY-0515 for Safety, Efficacy, and Pharmacodynamics in Participants With Huntington's Disease
Dapagliflozin and Endothelin Receptor Antagonism in Large Vessel Vasculitis (DERAIL-LVV)
The NAD-HD Study: A Study to Investigate Efficacy and Safety of Nicotinamide Riboside Compared With Placebo in Huntington's Disease
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Early Biomarkers in Premanifest Huntington's Disease Gene Carriers: a Pilot Study
Page 1 of 4Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →